Anlon Healthcare Lists at ₹92 with Modest Premium, Trades Steady Near Issue Price

Mumbai, September 3, 2025 –Anlon Healthcare Limited (Symbol: AHCL) shares debuted on the exchange at ₹92.00 (1.1% premium), matching the top of its IPO price band (₹86–₹91). This listing follows the company’s ₹121 crore IPO, which garnered strong interest from investors, closing with an overall subscription level of 7.12 times the offer.

Listing Day Performance

The stock traded at ₹91.90, up ₹0.90 (0.99%) from the issue price (₹91.00) at 11:30 AM. The stock has traded in a range of ₹91.00 – ₹92.50, with a VWAP of ₹91.96 post debut. The volume was quite reassuring, trading volumes of 22.68 lakh shares and a turnover of almost ₹20.86 crores. The company’s market cap was ₹485.80 crores, with a higher number of sell orders than buy orders.

IPO Recap

The ₹121 crore IPO consisted of a fresh issue of 1.33 crore shares in a price range of ₹86-₹91. There was no offer for sale (OFS) component. It was oversubscribed 7.13 times between August 26 and 29, 2025. While QIBs showed muted interest at 1.07×, strong retail demand (47.3×) and NII participation (10.61×) drove the response. The company plans to use proceeds for expansion, debt repayment, and working capital.

Founded in 2013, Anlon Healthcare owns a WHO-GMP, GMP, and ISO-certified facility in Rajkot, Gujarat. It manufactures APIs, Pharmaceutical Intermediates, Nutraceuticals, and Veterinary/Personal Care Ingredients. In the case of Anlon Healthcare, revenue and profit stood at ₹12,045.51 lakh and ₹ 2,051.79 lakh, respectively, in FY25, nearly twice those in FY24.

REF: https://www.nseindia.com/get-quotes/equity?symbol=AHCL

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations